| Sequence 1: | NP_000129.3 | Gene: | FBN1 / 2200 | HGNCID: | 3603 | Length: | 2871 | Species: | Homo sapiens |
|---|---|---|---|---|---|---|---|---|---|
| Sequence 2: | NP_114013.2 | Gene: | Fbn1 / 83727 | RGDID: | 620908 | Length: | 2872 | Species: | Rattus norvegicus |
| Alignment Length: | 2873 | Identity: | 2766/2873 - (96%) |
|---|---|---|---|
| Similarity: | 2833/2873 - (98%) | Gaps: | 3/2873 - (0%) |
- Green bases have known domain annotations that are detailed below.
|
Human 1 MRRGRLLEIALGFTVLLASYTSHGADANLEAGNVKETRASRAKRRGGGGHDALKGPNVCGSRYNA 65
Human 66 YCCPGWKTLPGGNQCIVPICRHSCGDGFCSRPNMCTCPSGQIAPSCGSRSIQHCNIRCMNGGSCS 130
Human 131 DDHCLCQKGYIGTHCGQPVCESGCLNGGRCVAPNRCACTYGFTGPQCERDYRTGPCFTVISNQMC 195
Human 196 QGQLSGIVCTKTLCCATVGRAWGHPCEMCPAQPHPCRRGFIPNIRTGACQDVDECQAIPGLCQGG 260
Human 261 NCINTVGSFECKCPAGHKLNEVSQKCEDIDECSTIPGICEGGECTNTVSSYFCKCPPGFYTSPDG 325
Human 326 TRCIDVRPGYCYTALTNGRCSNQLPQSITKMQCCCDAGRCWSPGVTVAPEMCPIRATEDFNKLCS 390
Human 391 VPMVIPGRPEYPPPPLGPIPPVLPVPPGFPPGPQIPVPRPPVEYLY--PSREPPRVLPVNVTDYC 453
Human 454 QLVRYLCQNGRCIPTPGSYRCECNKGFQLDLRGECIDVDECEKNPCAGGECINNQGSYTCQCRAG 518
Human 519 YQSTLTRTECRDIDECLQNGRICNNGRCINTDGSFHCVCNAGFHVTRDGKNCEDMDECSIRNMCL 583
Human 584 NGMCINEDGSFKCICKPGFQLASDGRYCKDINECETPGICMNGRCVNTDGSYRCECFPGLAVGLD 648
Human 649 GRVCVDTHMRSTCYGGYKRGQCIKPLFGAVTKSECCCASTEYAFGEPCQPCPAQNSAEYQALCSS 713
Human 714 GPGMTSAGSDINECALDPDICPNGICENLRGTYKCICNSGYEVDSTGKNCVDINECVLNSLLCDN 778
Human 779 GQCRNTPGSFVCTCPKGFIYKPDLKTCEDIDECESSPCINGVCKNSPGSFICECSSESTLDPTKT 843
Human 844 ICIETIKGTCWQTVIDGRCEININGATLKSQCCSSLGAAWGSPCTLCQVDPICGKGYSRIKGTQC 908
Human 909 EDIDECEVFPGVCKNGLCVNTRGSFKCQCPSGMTLDATGRICLDIRLETCFLRYEDEECTLPIAG 973
Human 974 RHRMDACCCSVGAAWGTEECEECPMRNTPEYEELCPRGPGFATKEITNGKPFFKDINECKMIPSL 1038
Human 1039 CTHGKCRNTIGSFKCRCDSGFALDSEERNCTDIDECRISPDLCGRGQCVNTPGDFECKCDEGYES 1103
Human 1104 GFMMMKNCMDIDECQRDPLLCRGGVCHNTEGSYRCECPPGHQLSPNISACIDINECELSAHLCPN 1168
Human 1169 GRCVNLIGKYQCACNPGYHSTPDRLFCVDIDECSIMNGGCETFCTNSEGSYECSCQPGFALMPDQ 1233
Human 1234 RSCTDIDECEDNPNICDGGQCTNIPGEYRCLCYDGFMASEDMKTCVDVNECDLNPNICLSGTCEN 1298
Human 1299 TKGSFICHCDMGYSGKKGKTGCTDINECEIGAHNCGKHAVCTNTAGSFKCSCSPGWIGDGIKCTD 1363
Human 1364 LDECSNGTHMCSQHADCKNTMGSYRCLCKEGYTGDGFTCTDLDECSENLNLCGNGQCLNAPGGYR 1428
Human 1429 CECDMGFVPSADGKACEDIDECSLPNICVFGTCHNLPGLFRCECEIGYELDRSGGNCTDVNECLD 1493
Human 1494 PTTCISGNCVNTPGSYICDCPPDFELNPTRVGCVDTRSGNCYLDIRPRGDNGDTACSNEIGVGVS 1558
Human 1559 KASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILEDIDECQELPGLCQGGKCI 1623
Human 1624 NTFGSFQCRCPTGYYLNEDTRVCDDVNECETPGICGPGTCYNTVGNYTCICPPDYMQVNGGNNCM 1688
Human 1689 DMRRSLCYRNYYADNQTCDGELLFNMTKKMCCCSYNIGRAWNKPCEQCPIPSTDEFATLCGSQRP 1753
Human 1754 GFVIDIYTGLPVDIDECREIPGVCENGVCINMVGSFRCECPVGFFYNDKLLVCEDIDECQNGPVC 1818
Human 1819 QRNAECINTAGSYRCDCKPGYRFTSTGQCNDRNECQEIPNICSHGQCIDTVGSFYCLCHTGFKTN 1883
Human 1884 DDQTMCLDINECERDACGNGTCRNTIGSFNCRCNHGFILSHNNDCIDVDECASGNGNLCRNGQCI 1948
Human 1949 NTVGSFQCQCNEGYEVAPDGRTCVDINECLLEPRKCAPGTCQNLDGSYRCICPPGYSLQNEKCED 2013
Human 2014 IDECVEEPEICALGTCSNTEGSFKCLCPEGFSLSSSGRRCQDLRMSYCYAKFEGGKCSSPKSRNH 2078
Human 2079 SKQECCCALKGEGWGDPCELCPTEPDEAFRQICPYGSGIIVGPDDSAVDMDECKEPDVCKHGQCI 2143
Human 2144 NTDGSYRCECPFGYILAGNECVDTDECSVGNPCGNGTCKNVIGGFECTCEEGFEPGPMMTCEDIN 2208
Human 2209 ECAQNPLLCAFRCVNTYGSYECKCPVGYVLREDRRMCKDEDECEEGKHDCTEKQMECKNLIGTYM 2273
Human 2274 CICGPGYQRRPDGEGCVDENECQTKPGICENGRCLNTRGSYTCECNDGFTASPNQDECLDNREGY 2338
Human 2339 CFTEVLQNMCQIGSSNRNPVTKSECCCDGGRGWGPHCEICPFQGTVAFKKLCPHGRGFMTNGADI 2403
Human 2404 DECKVIHDVCRNGECVNDRGSYHCICKTGYTPDITGTSCVDLNECNQAPKPCNFICKNTEGSYQC 2468
Human 2469 SCPKGYILQEDGRSCKDLDECATKQHNCQFLCVNTIGGFTCKCPPGFTQHHTSCIDNNECTSDIN 2533
Human 2534 LCGSKGICQNTPGSFTCECQRGFSLDQTGSSCEDVDECEGNHRCQHGCQNIIGGYRCSCPQGYLQ 2598
Human 2599 HYQWNQCVDENECLSAHICGGASCHNTLGSYKCMCPAGFQYEQFSGGCQDINECGSAQAPCSYGC 2663
Human 2664 SNTEGGYLCGCPPGYFRIGQGHCVSGMGMGRGNPEPPVSGEMDDNSLSPEACYECKINGYPKRGR 2728
Human 2729 KRRSTNETDASNIEDQSETEANVSLASWDVEKTAIFAFNISHVSNKVRILELLPALTTLTNHNRY 2793
Human 2794 LIESGNEDGFFKINQKEGISYLHFTKKKPVAGTYSLQISSTPLYKKKELNQLEDKYDKDYLSGEL 2858
Human 2859 GDNLKMKIQVLLH 2871 |
| Gene | Sequence | Domain | Region | External ID | Identity |
|---|---|---|---|---|---|
| FBN1 | NP_000129.3 | EGF_CA | 910..940 | CDD:429571 | 26/29 (90%) |
| TB | 966..1008 | CDD:459903 | 38/41 (93%) | ||
| EGF_CA | 1070..1104 | CDD:214542 | 33/33 (100%) | ||
| EGF_CA | 1113..1149 | CDD:214542 | 33/35 (94%) | ||
| EGF_CA | 1155..1188 | CDD:214542 | 30/32 (94%) | ||
| vWFA | <1194..1235 | CDD:469594 | 39/40 (98%) | ||
| EGF_3 | 1326..1361 | CDD:463759 | 33/34 (97%) | ||
| EGF_3 | 1367..1402 | CDD:463759 | 33/34 (97%) | ||
| EGF_CA | 1446..1486 | CDD:214542 | 38/39 (97%) | ||
| EGF_CA | 1487..1518 | CDD:214542 | 29/30 (97%) | ||
| TB | 1549..1589 | CDD:459903 | 37/39 (95%) | ||
| EGF_CA | 1606..1638 | CDD:214542 | 31/31 (100%) | ||
| EGF_CA | 1648..1687 | CDD:214542 | 38/38 (100%) | ||
| TB | 1705..1748 | CDD:459903 | 42/42 (100%) | ||
| EGF_CA | 1766..1796 | CDD:429571 | 29/29 (100%) | ||
| EGF_CA | 1808..1840 | CDD:214542 | 31/31 (100%) | ||
| vWFA | <1847..1886 | CDD:469594 | 37/38 (97%) | ||
| EGF_CA | 1930..1972 | CDD:214542 | 38/41 (93%) | ||
| EGF_CA | 1973..2008 | CDD:238011 | 31/34 (91%) | ||
| EGF_CA | 2013..2043 | CDD:429571 | 29/29 (100%) | ||
| TB | 2068..2111 | CDD:459903 | 42/42 (100%) | ||
| EGF_CA | 2127..2165 | CDD:214542 | 36/37 (97%) | ||
| EGF_CA | 2166..2205 | CDD:214542 | 38/38 (100%) | ||
| vWFA | <2289..2328 | CDD:469594 | 36/38 (95%) | ||
| TB | <2357..2390 | CDD:459903 | 30/32 (94%) | ||
| vWFA | <2442..2482 | CDD:469594 | 39/39 (100%) | ||
| EGF_CA | 2485..2514 | CDD:429571 | 28/28 (100%) | ||
| EGF_CA | 2524..2566 | CDD:214542 | 37/41 (90%) | ||
| EGF_CA | 2567..>2596 | CDD:214542 | 28/28 (100%) | ||
| EGF_CA | 2607..2638 | CDD:214542 | 29/30 (97%) | ||
| Fibrillin_U_N | 48..82 | CDD:436338 | 33/33 (100%) | ||
| TB | 194..>227 | CDD:459903 | 32/32 (100%) | ||
| EGF_CA | 246..>276 | CDD:214542 | 29/29 (100%) | ||
| EGF_CA | 288..329 | CDD:214542 | 38/40 (95%) | ||
| TB | 343..389 | CDD:459903 | 43/45 (96%) | ||
| EGF_CA | 490..521 | CDD:214542 | 28/30 (93%) | ||
| EGF_CA | 530..571 | CDD:214542 | 40/40 (100%) | ||
| EGF_CA | 572..612 | CDD:214542 | 39/39 (100%) | ||
| EGF_CA | 613..646 | CDD:214542 | 32/32 (100%) | ||
| TB | 668..711 | CDD:459903 | 41/42 (98%) | ||
| EGF_CA | 765..806 | CDD:238011 | 39/40 (98%) | ||
| TB | 860..>890 | CDD:459903 | 28/29 (97%) | ||
| Fbn1 | NP_114013.2 | Fibrillin_U_N | 48..82 | CDD:436338 | 33/33 (100%) |
| TB | 194..>227 | CDD:459903 | 32/32 (100%) | ||
| EGF_CA | 246..>276 | CDD:214542 | 29/29 (100%) | ||
| EGF_CA | 288..329 | CDD:214542 | 38/40 (95%) | ||
| TB | 343..389 | CDD:459903 | 43/45 (96%) | ||
| EGF_CA | 491..522 | CDD:214542 | 28/30 (93%) | ||
| EGF_CA | 531..572 | CDD:214542 | 40/40 (100%) | ||
| EGF_CA | 573..613 | CDD:214542 | 39/39 (100%) | ||
| EGF_CA | 614..647 | CDD:214542 | 32/32 (100%) | ||
| TB | 669..712 | CDD:459903 | 41/42 (98%) | ||
| EGF_CA | 766..>797 | CDD:214542 | 30/30 (100%) | ||
| TB | 861..>891 | CDD:459903 | 28/29 (97%) | ||
| EGF_CA | 911..941 | CDD:473889 | 26/29 (90%) | ||
| TB | 967..1009 | CDD:459903 | 38/41 (93%) | ||
| EGF_CA | 1071..1105 | CDD:214542 | 33/33 (100%) | ||
| EGF_CA | 1114..1150 | CDD:214542 | 33/35 (94%) | ||
| FXa_inhibition | 1202..1237 | CDD:464251 | 33/34 (97%) | ||
| EGF_3 | 1327..1362 | CDD:463759 | 33/34 (97%) | ||
| EGF_3 | 1368..1403 | CDD:463759 | 33/34 (97%) | ||
| EGF_CA | 1447..1487 | CDD:214542 | 38/39 (97%) | ||
| EGF_CA | 1488..1519 | CDD:214542 | 29/30 (97%) | ||
| TB | 1550..1590 | CDD:459903 | 37/39 (95%) | ||
| EGF_CA | 1607..1639 | CDD:214542 | 31/31 (100%) | ||
| EGF_CA | 1649..1688 | CDD:214542 | 38/38 (100%) | ||
| TB | 1706..1749 | CDD:459903 | 42/42 (100%) | ||
| EGF_CA | 1767..1797 | CDD:429571 | 29/29 (100%) | ||
| EGF_CA | 1809..1841 | CDD:214542 | 31/31 (100%) | ||
| EGF_CA | 1931..1973 | CDD:214542 | 38/41 (93%) | ||
| EGF_CA | 1974..2009 | CDD:238011 | 31/34 (91%) | ||
| EGF_CA | 2014..2044 | CDD:429571 | 29/29 (100%) | ||
| TB | 2069..2112 | CDD:459903 | 42/42 (100%) | ||
| EGF_CA | 2128..2166 | CDD:214542 | 36/37 (97%) | ||
| EGF_CA | 2167..2206 | CDD:214542 | 38/38 (100%) | ||
| TB | <2358..2391 | CDD:459903 | 30/32 (94%) | ||
| vWFA | <2443..2483 | CDD:469594 | 39/39 (100%) | ||
| EGF_CA | 2486..2515 | CDD:429571 | 28/28 (100%) | ||
| EGF_CA | 2525..2567 | CDD:214542 | 37/41 (90%) | ||
| EGF_CA | 2568..>2597 | CDD:214542 | 28/28 (100%) | ||
| EGF_CA | 2608..2639 | CDD:214542 | 29/30 (97%) |